Personal information

Verified email domains

臨床生化學、分子檢驗學、癌症生物學
Taiwan

Activities

Employment (1)

National Taiwan University: Taipei, TW

2019-08-01 to present | Associate Professor (Department of Clinical Laboratory Scienses and Medical Biotechnology)
Employment
Source: Self-asserted source
KANG-YI SU

Education and qualifications (1)

National Taiwan University: Taipei, TW

Ph.D. (Institute of Molecular Medicine, College of Medicine)
Education
Source: check_circle
National Taiwan University

Works (50 of 90)

Items per page:
Page 1 of 2

A Lung Cancer Mouse Model Database

bioRxiv
2024 | Other
EID:

2-s2.0-85197984429

Part of ISSN: 26928205
Contributors: Cai, L.; Gao, Y.; DeBerardinis, R.J.; Acquaah-Mensah, G.; Aidinis, V.; Beane, J.E.; Biswal, S.; Chen, T.; Concepcion-Crisol, C.P.; Grüner, B.M. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

Epigenomic biomarkers insights in PBMCs for prognostic assessment of ECMO-treated cardiogenic shock patients

Clinical Epigenetics
2024 | Journal article
EID:

2-s2.0-85205605515

Part of ISSN: 18687083 18687075
Contributors: Hsiao, Y.-J.; Chiang, S.-C.; Wang, C.-H.; Chi, N.-H.; Yu, H.-Y.; Hong, T.-H.; Chen, H.-Y.; Lin, C.-Y.; Kuo, S.-W.; Su, K.-Y. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

Interleukin-37 exacerbates liver inflammation and promotes IFN-γ production in NK cells

International Immunopharmacology
2024 | Journal article
EID:

2-s2.0-85203414153

Part of ISSN: 18781705 15675769
Contributors: Lin, C.-I.; Wang, Y.-W.; Su, K.-Y.; Chuang, Y.-H.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

DNAJB4/HLJ1 deficiency sensitizes diethylnitrosamine-induced hepatocarcinogenesis with peritumoral STAT3 activation

Cell Biology and Toxicology
2024-12-30 | Journal article
Contributors: Wei-Jia Luo; Wei-Lun Hsu; Chih-Yun Lu; Min-Hui Chien; Jung-Hsuan Chang; Kang-Yi Su
Source: check_circle
Crossref

Correction to: The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan (Targeted Oncology, (2022), 17, 3, (295-306), 10.1007/s11523-022-00878-x)

Targeted Oncology
2023 | Journal article
EID:

2-s2.0-85141404276

Contributors: Huang, Y.-H.; Hsu, K.-H.; Tseng, J.-S.; Yang, T.-Y.; Chen, K.-C.; Su, K.-Y.; Yu, S.-L.; Chen, J.J.W.; Chang, G.-C.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

LCRMP-1 is required for spermatogenesis and stabilises spermatid F-actin organization via the PI3K-Akt pathway

Communications Biology
2023 | Journal article
EID:

2-s2.0-85152117536

Part of ISSN: 23993642
Contributors: Chang, J.-H.; Chou, C.-H.; Wu, J.-C.; Liao, K.-M.; Luo, W.-J.; Hsu, W.-L.; Chen, X.-R.; Yu, S.-L.; Pan, S.-H.; Yang, P.-C. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasis

Cancer Medicine
2023 | Journal article
EID:

2-s2.0-85159815858

Part of ISSN: 20457634
Contributors: Tsai, T.-H.; Gow, C.-H.; Liu, Y.-N.; Tsai, M.-F.; Chang, T.-H.; Wu, S.-G.; Hsieh, M.-S.; Su, K.-Y.; Shih, J.-Y.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

Tissue Proteogenomic Landscape Reveals the Role of Uncharacterized SEL1L3 in Progression and Immunotherapy Response in Lung Adenocarcinoma

Journal of Proteome Research
2023 | Journal article
EID:

2-s2.0-85142001157

Contributors: Shen, C.-Y.; Chang, W.-H.; Chen, Y.-J.; Weng, C.-W.; Regmi, P.; Kier, M.K.K.; Su, K.-Y.; Chang, G.-C.; Chen, J.-S.; Chen, Y.-J. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages

Lung Cancer
2023 | Journal article
EID:

2-s2.0-85169808409

Part of ISSN: 18728332 01695002
Contributors: Ho, H.; Yu, S.-L.; Chen, H.-Y.; Yuan, S.-S.; Su, K.-Y.; Hsu, Y.-C.; Hsu, C.-P.; Chuang, C.-Y.; Chang, Y.-H.; Li, Y.-C. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

High-fat diet induces C-reactive protein secretion, promoting lung adenocarcinoma via immune microenvironment modulation

Disease Models & Mechanisms
2023-11-01 | Journal article
Contributors: Wei-Lun Hsu; Yun-Ting Hsieh; Wei-Ming Chen; Min-Hui Chien; Wei-Jia Luo; Jung-Hsuan Chang; Kevin Devlin; Kang-Yi Su
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Senomorphic effect of diphenyleneiodonium through AMPK/MFF/DRP1 mediated mitochondrial fission

Biomedicine & Pharmacotherapy
2023-06 | Journal article
Contributors: Keng-Mao Liao; Chih-Jung Chen; Wei-Jia Luo; Chen-Wei Hsu; Sung-Liang Yu; Pan-Chyr Yang; Kang-Yi Su
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Impact of PD-L1 Expression and Tumor Microenvironments on Osimertinib Efficacy in Pretreated Non-Small-Cell Lung Cancer Harboring an Acquired EGFRT790M Mutation

SSRN
2022 | Other
EID:

2-s2.0-85177987654

Part of ISSN: 15565068
Contributors: Yang, C.-Y.; Liao, W.-Y.; Ho, C.-C.; Chen, K.-Y.; Tsai, T.-H.; Hsu, C.-L.; Su, K.-Y.; Chang, Y.-L.; Wu, C.-T.; Liao, B.-C. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

Impact of PD-L1 Expression and Tumor Microenvironments on Osimertinib Efficacy in Pretreated Non-Small-Cell Lung Cancer Harboring an Acquired EGFRT790M Mutation

SSRN
2022 | Other
EID:

2-s2.0-85142629691

Part of ISSN: 15565068
Contributors: Yang, C.-Y.; Liao, W.-Y.; Ho, C.-C.; Chen, K.-Y.; Tsai, T.-H.; Hsu, C.-L.; Su, K.-Y.; Chang, Y.-L.; Wu, C.-T.; Liao, B.-C. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients

Scientific Reports
2022 | Journal article
EID:

2-s2.0-85131784604

Part of ISSN: 20452322
Contributors: Hsu, K.-H.; Tseng, J.-S.; Yang, T.-Y.; Chen, K.-C.; Su, K.-Y.; Yu, S.-L.; Chen, J.J.W.; Huang, Y.-H.; Chang, G.-C.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma

Cancer research and treatment
2022 | Journal article
EID:

2-s2.0-85128493393

Part of ISSN: 20059256
Contributors: Huang, Y.-H.; Hsu, K.-H.; Chin, C.-S.; Tseng, J.-S.; Yang, T.-Y.; Chen, K.-C.; Su, K.-Y.; Yu, S.-L.; Chen, J.J.W.; Chang, G.-C.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan

Targeted Oncology
2022 | Journal article
EID:

2-s2.0-85128768264

Part of ISSN: 1776260X 17762596
Contributors: Huang, Y.-H.; Hsu, K.-H.; Tseng, J.-S.; Yang, T.-Y.; Chen, K.-C.; Su, K.-Y.; Yu, S.-L.; Chen, J.J.W.; Chang, G.-C.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Uracil-DNA Glycosylase Assay by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry Analysis

Journal of Visualized Experiments
2022 | Journal article
EID:

2-s2.0-85129547935

Part of ISSN: 1940087X
Contributors: Chang, H.-L.; Su, K.-Y.; Goodman, S.D.; Cheng, W.-C.; Lin, L.-I.; Yang, Y.-C.; Chang, S.-Y.; Fang, W.-H.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

Various impacts of driver mutations on the PD-L1 expression of NSCLC

PLoS ONE
2022 | Journal article
EID:

2-s2.0-85136154124

Part of ISSN: 19326203
Contributors: Chu, C.-H.; Huang, Y.-H.; Lee, P.-H.; Hsu, K.-H.; Chen, K.-C.; Su, K.-Y.; Yu, S.-L.; Tseng, J.-S.; Yang, T.-Y.; Chang, G.-C.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

HLJ1 amplifies endotoxin-induced sepsis severity by promoting IL-12 heterodimerization in macrophages

eLife
2022-08-19 | Journal article
Part of ISSN: 2050-084X
Contributors: KANG-YI SU
Source: Self-asserted source
KANG-YI SU
grade
Preferred source (of 2)‎

Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid

Cancers
2022-06-07 | Journal article
Contributors: Pei-Ya Liao; Wei-Fan Ou; Kang-Yi Su; Ming-Hsi Sun; Chih-Mei Huang; Kun-Chieh Chen; Kuo-Hsuan Hsu; Sung-Liang Yu; Yen-Hsiang Huang; Jeng-Sen Tseng et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Genetic Deletion of HLJ1 Does Not Affect Blood Coagulation in Mice

International Journal of Molecular Sciences
2022-02-13 | Journal article
Contributors: Man-Chen Hsu; Wei-Jia Luo; Bei-Chia Guo; Chia-Hui Chen; Po-An Hu; Yi-Hsuan Tsai; Kang-Yi Su; Tzong-Shyuan Lee
Source: check_circle
Crossref
grade
Preferred source (of 4)‎

Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes

Biomolecules
2022-01-19 | Journal article
Contributors: Chia-Ching Chang; Min-Shu Hsieh; Mong-Wei Lin; Yi-Hsuan Lee; Yi-Jing Hsiao; Kang-Yi Su; Te-Jen Su; Sung-Liang Yu; Jin-Shing Chen
Source: check_circle
Crossref
grade
Preferred source (of 4)‎

HLJ1 amplifies endotoxin–induced sepsis severity by promoting IL-12 heterodimerization in macrophages

2022-01-06 | Preprint
Contributors: Wei-Jia Luo; Sung-Liang Yu; Chia-Ching Chang; Min-Hui Chien; Keng-Mao Liao; Ya-Ling Chang; Ya-Hui Chuang; Jeremy J.W. Chen; Pan-Chyr Yang; Kang-Yi Su
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Measurement of uracil-DNA glycosylase activity by matrix assisted laser desorption/ionization time-of-flight mass spectrometry technique

DNA Repair
2021 | Journal article
EID:

2-s2.0-85096860075

Part of ISSN: 15687856 15687864
Contributors: Chang, H.-L.; Su, K.-Y.; Goodman, S.D.; Yen, R.-S.; Cheng, W.-C.; Yang, Y.-C.; Lin, L.-I.; Chang, S.-Y.; Fang, W.-H.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment

Oncology (Switzerland)
2021 | Journal article
EID:

2-s2.0-85091323522

Part of ISSN: 14230232 00302414
Contributors: Tseng, J.-S.; Hsu, K.-H.; Zheng, Z.-R.; Yang, T.-Y.; Chen, K.-C.; Huang, Y.-H.; Su, K.-Y.; Yu, S.-L.; Chang, G.-C.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan

JTO Clinical and Research Reports
2021 | Journal article
EID:

2-s2.0-85109577287

Part of ISSN: 26663643
Contributors: Wu, S.-G.; Liao, W.-Y.; Su, K.-Y.; Yu, S.-L.; Huang, Y.-L.; Yu, C.-J.; Chih-Hsin Yang, J.; Shih, J.-Y.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M (Scientific Reports, (2021), 11, 1, (12084), 10.1038/s41598-021-91657-7)

Scientific Reports
2021 | Journal article
EID:

2-s2.0-85114244950

Part of ISSN: 20452322
Contributors: Huang, Y.-H.; Tseng, J.-S.; Hsu, K.-H.; Chen, K.-C.; Su, K.-Y.; Yu, S.-L.; Chen, J.J.W.; Yang, T.-Y.; Chang, G.-C.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M

Scientific Reports
2021 | Journal article
EID:

2-s2.0-85107592043

Part of ISSN: 20452322
Contributors: Huang, Y.-H.; Tseng, J.-S.; Hsu, K.-H.; Chen, K.-C.; Su, K.-Y.; Yu, S.-L.; Chen, J.J.W.; Yang, T.-Y.; Chang, G.-C.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Transthyretin as a Biomarker to Predict and Monitor Major Depressive Disorder Identified by Whole-Genome Transcriptomic Analysis in Mouse Models

Biomedicines
2021-08-31 | Journal article
Contributors: Sung-Liang Yu; Selina Shih-Ting Chu; Min-Hui Chien; Po-Hsiu Kuo; Pan-Chyr Yang; Kang-Yi Su
Source: check_circle
Crossref
grade
Preferred source (of 4)‎

ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients

Scientific Reports
2020 | Journal article
EID:

2-s2.0-85097031474

Part of ISSN: 20452322
Contributors: Chang, G.-C.; Yang, T.-Y.; Chen, K.-C.; Hsu, K.-H.; Huang, Y.-H.; Su, K.-Y.; Yu, S.-L.; Tseng, J.-S.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib

Oncologist
2020 | Journal article
EID:

2-s2.0-85084544980

Part of ISBN:

1549490X 10837159

Contributors: Yang, C.-Y.; Liao, W.-Y.; Ho, C.-C.; Chen, K.-Y.; Tsai, T.-H.; Hsu, C.-L.; Liu, Y.-N.; Su, K.-Y.; Chang, Y.-L.; Wu, C.-T. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Proofreading of single nucleotide insertion/deletion replication errors analyzed by MALDI-TOF mass spectrometry assay

DNA Repair
2020 | Journal article
EID:

2-s2.0-85078872170

Part of ISBN:

15687856 15687864

Contributors: Chang, H.-L.; Su, K.-Y.; Goodman, S.D.; Chou, N.-A.; Lin, K.-C.; Cheng, W.-C.; Lin, L.-I.; Chang, S.-Y.; Fang, W.-H.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression

Cell
2020 | Journal article
EID:

2-s2.0-85087414083

Part of ISSN: 10974172 00928674
Contributors: Chen, Y.-J.; Roumeliotis, T.I.; Chang, Y.-H.; Chen, C.-T.; Han, C.-L.; Lin, M.-H.; Chen, H.-W.; Chang, G.-C.; Chang, Y.-L.; Wu, C.-T. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

Copy Number Alterations of Depressed Colorectal Neoplasm Predict the Survival and Response to Oxaliplatin in Proximal Colon Cancer

Cancers
2020-06 | Journal article | Author
Contributors: Li-Chun Chang; Han-Mo Chiu; Bing-Ching Ho; Min-Hsuan Chen; Yin-Chen Hsu; Wei-Tzu Chiu; KANG-YI SU; Chia-Tung Shun; Jin-Tung Liang; Sung-Liang Yu et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors

European Journal of Cancer
2020-01 | Journal article
Contributors: Ching-Yao Yang; Wei-Yu Liao; Chao-Chi Ho; Kuan-Yu Chen; Tzu-Hsiu Tsai; Chia-Lin Hsu; Kang-Yi Su; Yih-Leong Chang; Chen-Tu Wu; Chia-Chi Hsu et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Copy Number Alterations Predict the Survival of Early Colorectal Cancer with Depressed Morphology

SSRN
2019 | Other
EID:

2-s2.0-85110794610

Part of ISSN: 15565068
Contributors: Chang, L.-C.; Chiu, H.-M.; Ho, B.-C.; Chen, M.-H.; Hsu, Y.-C.; Chiu, W.-T.; Su, K.-Y.; Shun, C.-T.; Liang, J.-T.; Sung-Liang et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patients

Lung Cancer
2019 | Journal article
EID:

2-s2.0-85057248957

Contributors: Hsu, K.-H.; Huang, Y.-H.; Tseng, J.-S.; Chen, K.-C.; Ku, W.-H.; Su, K.-Y.; Chen, J.J.W.; Chen, H.-W.; Yu, S.-L.; Yang, T.-Y. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Improved Dried Blood Spot-Based Metabolomics Analysis by a Postcolumn Infused-Internal Standard Assisted Liquid Chromatography-Electrospray Ionization Mass Spectrometry Method

Analytical Chemistry
2019 | Journal article
EID:

2-s2.0-85070934127

Part of ISBN:

15206882 00032700

Contributors: Chepyala, D.; Kuo, H.-C.; Su, K.-Y.; Liao, H.-W.; Wang, S.-Y.; Chepyala, S.R.; Chang, L.-C.; Kuo, C.-H.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Metabolomics Investigation of Voriconazole-Induced Hepatotoxicity in Mice

Chemical Research in Toxicology
2019 | Journal article
EID:

2-s2.0-85072234216

Part of ISBN:

15205010 0893228X

Contributors: Wu, S.-L.; Wei, T.-Y.; Lin, S.-W.; Su, K.-Y.; Kuo, C.-H.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Perinatal polychlorinated biphenyls and polychlorinated dibenzofurans exposure are associated with DNA methylation changes lasting to early adulthood: Findings from Yucheng second generation

Environmental Research
2019-03 | Journal article
Contributors: Kang-Yi Su; Ming-Chieh Li; Nian-Wei Lee; Bing-Ching Ho; Chiou-Ling Cheng; Yu-Chen Chuang; Sung-Liang Yu; Yue Leon Guo
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay

DNA Repair
2018 | Journal article
EID:

2-s2.0-85037366220

Contributors: Su, K.-Y.; Lai, H.-M.; Goodman, S.D.; Hu, W.-Y.; Cheng, W.-C.; Lin, L.-I.; Yang, Y.-C.; Fang, W.-H.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Characteristics and Predictive Value of PD-L1 Status in Real-World NonSmall Cell Lung Cancer Patients

Journal of Immunotherapy
2018 | Journal article
EID:

2-s2.0-85048738706

Contributors: Tseng, J.-S.; Yang, T.-Y.; Wu, C.-Y.; Ku, W.-H.; Chen, K.-C.; Hsu, K.-H.; Huang, Y.-H.; Su, K.-Y.; Yu, S.-L.; Chang, G.-C.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer

Lung Cancer
2018 | Journal article
EID:

2-s2.0-85054853801

Contributors: Lin, M.-W.; Su, K.-Y.; Su, T.-J.; Chang, C.-C.; Lin, J.-W.; Lee, Y.-H.; Yu, S.-L.; Chen, J.-S.; Hsieh, M.-S.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

DNA polymerase I proofreading exonuclease activity is required for endonuclease V repair pathway both in vitro and in vivo

DNA Repair
2018 | Journal article
EID:

2-s2.0-85042846544

Contributors: Su, K.-Y.; Lin, L.-I.; Goodman, S.D.; Yen, R.-S.; Wu, C.-Y.; Chang, W.-C.; Yang, Y.-C.; Cheng, W.-C.; Fang, W.-H.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

FAM198B is associated with prolonged survival and inhibits metastasis in lung adenocarcinoma via blockage of ERK-Mediated MMP-1 expression

Clinical Cancer Research
2018 | Journal article
EID:

2-s2.0-85042230149

Contributors: Hsu, C.-Y.; Chang, G.-C.; Chen, Y.-J.; Hsu, Y.-C.; Hsiao, Y.-J.; Su, K.-Y.; Chen, H.-Y.; Lin, C.-Y.; Chen, J.-S.; Chen, Y.-J. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Intercalated treatment following rebiopsy is associated with a shorter progression-free survival of osimertinib treatment

Cancer Research and Treatment
2018 | Journal article
EID:

2-s2.0-85054709197

Contributors: Tseng, J.-S.; Yang, T.-Y.; Chen, K.-C.; Hsu, K.-H.; Huang, Y.-H.; Su, K.-Y.; Yu, S.-L.; Chang, G.-C.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

MIP-1γ and SDF-1α Confer to High-Fat Diet Enhanced Lung Adenocarcinoma Progression

SSRN
2018 | Other
EID:

2-s2.0-85114775399

Part of ISSN: 15565068
Contributors: Hsieh, Y.-T.; Chien, M.-H.; Liao, K.-M.; Luo, W.-J.; Wong, K.-I.; Su, K.-Y.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier

Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma

PLoS ONE
2018 | Journal article
EID:

2-s2.0-85056574938

Contributors: Su, K.-Y.; Tseng, J.-S.; Liao, K.-M.; Yang, T.-Y.; Chen, K.-C.; Hsu, K.-H.; Yang, P.-C.; Yu, S.-L.; Chang, G.-C.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study

The Lancet Respiratory Medicine
2018 | Journal article
EID:

2-s2.0-85039450519

Contributors: Lin, C.-C.; Shih, J.-Y.; Yu, C.-J.; Ho, C.-C.; Liao, W.-Y.; Lee, J.-H.; Tsai, T.-H.; Su, K.-Y.; Hsieh, M.-S.; Chang, Y.-L. et al.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎

Proofreading and DNA repair assay using single nucleotide extension and MALDI-TOF mass spectrometry analysis

Journal of Visualized Experiments
2018 | Journal article
EID:

2-s2.0-85049830811

Contributors: Su, K.-Y.; Goodman, S.D.; Lai, H.-M.; Yen, R.-S.; Hu, W.-Y.; Cheng, W.-C.; Lin, L.-I.; Yang, Y.-C.; Fang, W.-H.
Source: Self-asserted source
KANG-YI SU via Scopus - Elsevier
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2

Peer review (14 reviews for 9 publications/grants)

Review activity for Biomedicine & pharmacotherapy. (3)
Review activity for British journal of cancer. (1)
Review activity for Clinical lung cancer. (2)
Review activity for European journal of cancer. (1)
Review activity for Heliyon. (1)
Review activity for Journal of the Formosan Medical Association. (3)
Review activity for Life sciences. (1)
Review activity for Pathology, research and practice. (1)
Review activity for Respiratory research. (1)